A TCGA survey for the RNASET2 mutation was recently carried out showing a 1 to 5% mutation rate for this gene in a wide range of human cancer types, with ovarian cancer showing as one of the highest rates [25]. The gene discussed is RNASET2; the disease is ovarian carcinoma.